Mexico Animal Healthcare - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The mexico animal healthcare market size is expected to increase from USD 2.13 billion in 2025 to USD 2.29 billion in 2026 and reach USD 3.34 billion by 2031, growing at a CAGR of 7.84% over 2026-2031. This report is Segmented by Product (Therapeutics [Vaccines, and More], Diagnostics [Immunodiagnostic Tests, Molecular Diagnostics, Diagnostic Imaging, Clinical Chemistry, and Other Diagnostics]), Animal Type (Dogs & Cats, and More), Route of Administration (Oral, and More), and End User (Veterinary Hospitals & Clinics, and More). The Market Forecasts are Provided in Terms of Value (USD).

Mexico Animal Healthcare Market Trends and Insights

Rising Companion Animal Expenditure

Urban pet ownership continues to reshape the Mexico animal healthcare market, with dogs and cats commanding nearly half of total demand. In June 2025, the Similares pharmacy chain launched Simi Pet Care, signaling retail recognition of companion-animal potential and extending low-cost veterinary medicines to price-sensitive consumers. Preventive visits, premium nutrition, and specialty treatments are increasingly common, supported by 2024 legislation that created free public veterinary clinics to raise the baseline standard of care. Together, private and public channels are broadening service coverage, spurring demand for diagnostics and vaccines, and building customer expectations for quality across the Mexico animal healthcare market.

Expansion of Livestock Industry and Animal Protein Demand

Livestock production generates more than 565 billion pesos annually and employs over 828,000 people, ensuring steady therapeutic consumption for cattle, swine, and poultry. Sector investment pledges of 105 billion pesos focus on plant upgrades and sustainability, while the July 2025 methane-reduction strategy requires specialized veterinary input on feed additives and genetics. Maintaining monthly cattle-export revenue of USD 25-30 million hinges on stringent surveillance, traceability, and certification - areas that continually enlarge the addressable base for the Mexico animal healthcare market.

High Cost of Veterinary Care and Products

Price sensitivity limits uptake of premium pharmaceuticals outside major metros. SENASICA’s February 2025 counterfeit-drug alert underscored risks when producers turn to unregulated channels. Currency swings elevate import costs for advanced biologics, while compliance fees keep legitimate prices high. Low-cost retail clinics and free public services soften the constraint but also compress margins for full-service hospitals in the Mexico animal healthcare market.

Other drivers and restraints analyzed in the detailed report include:

• Technological Innovation in Veterinary Diagnostics and Therapeutics
• Government Support for Animal Health and Biosecurity Programs
• Limited Veterinary Infrastructure in Rural Areas

Segment Analysis

Therapeutics commanded 61.65% of the Mexico animal healthcare market share in 2025, reflecting entrenched treatment-oriented practices across livestock and companion-animal segments. Demand spikes following the screwworm outbreak sustained high volumes for parasiticides, wound treatments, and antibiotics. Agrovet Market’s February 2025 launch of Opticlox for bovine eye infections illustrates continuing formulation upgrades aimed at high-value cattle.

Recent shifts toward surveillance and export compliance are expanding diagnostics faster than any other category at a 8.81% CAGR, underpinning an incremental lift in the Mexico animal healthcare market size. Point-of-care test kits provide immediate, actionable results for ranchers facing tight shipment windows, while immunoassays and molecular panels gain currency in urban clinics catering to preventive-care minded pet owners. Modalities such as digital radiography are also moving into secondary cities, narrowing the historical gap with human healthcare standards.

Urban dogs and cats represent 48.43% of volume and value demand, riding a wave of humanization that fuels specialty diets, vaccinations, and dental care. Insurance uptake and retail clinic chains both amplify expenditure depth within the companion cohort. Alongside, poultry health needs are expanding more rapidly than any other animal type, growing at a 8.76% CAGR as integrated producers tighten biosecurity after 2024 avian-influenza scares.

Beef and dairy cattle remain cornerstone users of reproductive hormones and mastitis-control drugs, leveraging Mexico’s fifth-place global herd ranking to secure export premiums. Swine and equine segments contribute stable baseline volumes, whereas aquaculture therapeutics hint at emerging niches that could widen the Mexico animal healthcare market size over the next decade.

Complete Report Scope:

• By Product
  • Therapeutics
    • Vaccines
    • Parasiticides
    • Anti-Infectives
    • Medical Feed Additives
    • Other Therapeutics
  • Diagnostics
    • Immunodiagnostic Tests
    • Molecular Diagnostics
    • Diagnostic Imaging
    • Clinical Chemistry
    • Other Diagnostics
• By Animal Type
  • Dogs & Cats
  • Horses
  • Ruminants
  • Swine
  • Poultry
  • Other Animal Types
• By Route Of Administration
  • Oral
  • Parenteral
  • Topical
  • Other Route of Administrations
• By End User
  • Veterinary Hospitals & Clinics
  • Reference Laboratories
  • Point-Of-Care / In-House Testing Settings
  • Academic & Research Institutes

List of Companies Covered in this Report:

• Agrovet Market Animal Health
• Bimeda
• Boehringer Ingelheim
• Ceva Santé Animale
• Covetrus
• Dechra Pharmaceuticals
• Elanco
• IDEXX
• Merck
• Patterson Veterinary
• Petco Vet Services México
• Phibro Animal Health
• Vetoquinol
• Virbac
• Zoetis

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support